300485 賽升藥業
按盤價 
10.820 +0.130 (+1.216%)
10.820 +0.130 (+1.216%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.533 | -2.027 | 3.023 | 6.187 | 13.300 |
| 總資產報酬率 ROA (%) | 1.449 | -1.920 | 2.862 | 5.874 | 12.585 |
| 投入資產回報率 ROIC (%) | 1.489 | -1.970 | 2.936 | 6.064 | 13.172 | 邊際利潤分析 |
| 銷售毛利率 (%) | 65.556 | 66.282 | 70.426 | 76.638 | 82.668 |
| 營業利潤率 (%) | 19.198 | -19.923 | 25.544 | 34.666 | 41.777 |
| 息稅前利潤/營業總收入 (%) | 18.889 | -20.470 | 25.414 | 34.602 | 40.704 |
| 淨利潤/營業總收入 (%) | 15.731 | -18.458 | 20.230 | 27.588 | 37.603 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 10.273 | -30.401 | -33.626 | 9.430 | 24.096 |
| 價值變動淨收益/利潤總額(%) | 107.942 | 129.395 | 131.033 | 83.309 | 72.533 |
| 營業外收支淨額/利潤總額(%) | -0.090 | 0.709 | 0.349 | -0.008 | 0.006 | 償債能力分析 |
| 流動比率 (X) | 21.796 | 20.860 | 26.300 | 17.621 | 17.298 |
| 速動比率 (X) | 20.906 | 19.868 | 24.219 | 16.432 | 15.907 |
| 資產負債率 (%) | 4.751 | 4.687 | 4.268 | 4.402 | 3.485 |
| 帶息債務/全部投入資本 (%) | 0.687 | 0.108 | 0.172 | 0.253 | 0.374 |
| 股東權益/帶息債務 (%) | 14,089.650 | 90,494.815 | 56,495.613 | 38,469.304 | 26,389.748 |
| 股東權益/負債合計 (%) | 1,990.274 | 2,016.513 | 2,222.370 | 2,147.677 | 2,737.166 |
| 利息保障倍數 (X) | -64.831 | 50.480 | -115.483 | -563.178 | -37.840 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.498 | 40.744 | 46.431 | 40.964 | 35.355 |
| 存貨周轉天數 (天) | 195.664 | 241.526 | 250.518 | 222.522 | 278.408 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
